Biofourmis
Because of new government support and increased comfort with connected technologies, healthcare providers will continue shoring up their virtual care capabilities, says Biofourmis CEO Kuldeep Singh Rajput.
Biofourmis has restructured its business to pursue its original focus on data-driven patient monitoring alongside its more recent interest in standalone and companion digital therapeutics.
The partnership leverages Biofourmis’ Biovitals platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and AI-based algorithms.
Also: DispatchHealth adds a new COO, and Saykara announces a new marketing VP.
Biofourmis founder and CEO Kuldeep Singh Rajput discusses remote monitoring's role in reaching patients at home and reducing contact with COVID-19-positive patients.
The new tool will be combined with Biofourmis' Biovitals platform and be able to give insights to cancer patients at home.
Also: Sandoz' digital therapeutics marketing steps out; Digital weight management tool Naturally Slim picks up new CFO.
Also: ActiGraph integrates with Signant Health; AiCure's adherence tool supports Syneos Health's clinical trials.
The acquisition will include Biovotions' wearables, patents, staff, partners and clients.